Tissue Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Tissue Diagnostics Market is segmented By Product (Reagents & Consumables and Instruments), Technology, Application, and Geography

Tissue Diagnostics Market Snapshot

Tissue Diagnostics Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Tissue-based diagnostics serves as one of the most important techniques for cancer diagnosis. The International Agency for Research on Cancer (IARC) predicts that, by 2030, the global burden is expected to increase to 21.7 million new cancer cases and 13 million cancer deaths, due to the growth and aging of the population, apart from other factors, such as smoking, poor diet, physical inactivity, and fewer childbirths. The tissue diagnostics capture the disease insights and the parameters that factor into the patient outcomes. Tissues generally enable personalized diagnosis & treatment. Samples usually consist of pieces of tissue obtained by various methods. These include small biopsies and large specimens removed at surgery. Other factors such as growing healthcare expenditure, and technological advancements in tissue diagnostics are the major factors driving the growth of the market.

Scope of the Report

As per the scope of the report, Tissue diagnostics involves monitoring, diagnosis, and management of different stages of cancer. The market is categorized based on product technology, and application.

By Product
Reagents & Consumables
By Technology
In-Situ Hybridization
Digital Pathology & Workflow Management
By Application
Breast Cancer
Prostate Cancer
Gastric Cancer
Other Cancers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Breast Cancer Segment is Expected to Register a Significant Growth in the Forecast Years

Based on the application, it is segmented into breast cancer, prostate cancer, gastric cancer, and others. The main factors attributed to the growth of this segment is the increasing burden of breast cancer. It is the most commonly diagnosed cancer among American women. In 2017, it was estimated by the American Cancer Society, that about 30% of the newly diagnosed cancers in women were breast cancers. Hence, the increasing cancer cases along with advancements in the field of tissue diagnostics are major factors contributing to the growth of the market in the forecast period.

Tissue Diagnostics Market 1

North America holds the Largest Share in the Tissue Diagnostics Market

The tissue diagnostics market holds the largest share in the North America region due to the increased awareness about the potential benefits of diagnostics among the population. The rising cancer burden along with a rapidly aging population is the key factor for market growth. According to the World Health Organization, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Moreover, rising disease burden is further pushing the need for effective and quick treatment options which is expected to propel the growth of the market, over the forecast period.

Tissue Diagnostics Market 2

Competitive Landscape

The global players into the tissue diagnostics market are Abbott Laboratories, Agilent Technologies, Inc., BioGenex Laboratories, Cancer Genetics, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Genomic Health, Inc., Merck KGaA and Thermo Fisher Scientific.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Cancer

      2. 4.2.2 Growing Healthcare Expenditure

      3. 4.2.3 Technological Advancements in Tissue Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Diagnosis And Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents & Consumables

    2. 5.2 By Technology

      1. 5.2.1 Immunohistochemistry

      2. 5.2.2 In-Situ Hybridization

      3. 5.2.3 Digital Pathology & Workflow Management

      4. 5.2.4 Others

    3. 5.3 By Application

      1. 5.3.1 Breast Cancer

      2. 5.3.2 Prostate Cancer

      3. 5.3.3 Gastric Cancer

      4. 5.3.4 Other Cancers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies, Inc.

      3. 6.1.3 BioGenex Laboratories

      4. 6.1.4 Cancer Genetics, Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Genomic Health, Inc.

      8. 6.1.8 Merck KGaA

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Tissue Diagnostics Market market is studied from 2018 - 2026.

The Tissue Diagnostics Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific are the major companies operating in Tissue Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!